Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).
Eur Urol Oncol
; 2023 Oct 06.
Article
en En
| MEDLINE
| ID: mdl-37806844
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Eur Urol Oncol
Año:
2023
Tipo del documento:
Article